CD40LG as a Prognostic Molecular Marker Regulates Tumor Microenvironment Through Immune Process in Breast Cancer.

Yuan, Manqiu; Pei, Jianying; Li, Ruihao; Tian, Lirong; He, Xin; Li, Yanping.

Afiliação

Yuan M; The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, People's Republic of China.
Pei J; Institute of Clinical Medicine, Gansu Province Maternal and Child-Care Hospital, Lanzhou, Gansu, People's Republic of China.
Li R; Department of Vascular Surgery, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, People's Republic of China.
Tian L; The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, People's Republic of China.
He X; The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, People's Republic of China.
Li Y; Department of Clinical Laboratory, The First Hospital of Lanzhou University, Lanzhou, Gansu, People's Republic of China.

Int J Gen Med ; 14: 8833-8846, 2021.

Article em En | MEDLINE | ID: mdl-34858051